Request for Covid-19 Impact Assessment of this Report
The classification of Nebulizer includes Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers, and the proportion of Pneumatic Nebulizers in 2016 is about 56%.
This report provides a complete quantitative data and qualitative analysis on the global market for Inhalation Therapy Nebuliser. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Inhalation Therapy Nebuliser was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Inhalation Therapy Nebuliser is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Inhalation Therapy Nebuliser, including the following market information:
Global Inhalation Therapy Nebuliser Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Inhalation Therapy Nebuliser Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Inhalation Therapy Nebuliser Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Inhalation Therapy Nebuliser Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Pneumatic Nebuliser
Ultrasonic Nebuliser
Mesh Nebuliser
Based on the Application:
COPD
Cystic Fibrosis
Asthma
Others
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Inhalation Therapy Nebuliser Industry
1.7 COVID-19 Impact: Inhalation Therapy Nebuliser Market Trends
2 Global Inhalation Therapy Nebuliser Quarterly Market Size Analysis
2.1 Inhalation Therapy Nebuliser Business Impact Assessment - COVID-19
2.1.1 Global Inhalation Therapy Nebuliser Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Inhalation Therapy Nebuliser Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Inhalation Therapy Nebuliser Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Inhalation Therapy Nebuliser Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Inhalation Therapy Nebuliser Factory Price by Manufacturers
3.3 Location of Key Manufacturers Inhalation Therapy Nebuliser Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Inhalation Therapy Nebuliser Market
3.5 Key Manufacturers Inhalation Therapy Nebuliser Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Inhalation Therapy Nebuliser Segments, By Type
4.1 Introduction
1.4.1 Pneumatic Nebuliser
1.4.2 Ultrasonic Nebuliser
1.4.3 Mesh Nebuliser
4.2 By Type, Global Inhalation Therapy Nebuliser Market Size, 2019-2021
4.2.1 By Type, Global Inhalation Therapy Nebuliser Market Size by Type, 2020-2021
4.2.2 By Type, Global Inhalation Therapy Nebuliser Price, 2020-2021
5 Impact of Covid-19 on Inhalation Therapy Nebuliser Segments, By Application
5.1 Overview
5.5.1 COPD
5.5.2 Cystic Fibrosis
5.5.3 Asthma
5.5.4 Others
5.2 By Application, Global Inhalation Therapy Nebuliser Market Size, 2019-2021
5.2.1 By Application, Global Inhalation Therapy Nebuliser Market Size by Application, 2019-2021
5.2.2 By Application, Global Inhalation Therapy Nebuliser Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 PARI GmbH
7.1.1 PARI GmbH Business Overview
7.1.2 PARI GmbH Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.1.3 PARI GmbH Inhalation Therapy Nebuliser Product Introduction
7.1.4 PARI GmbH Response to COVID-19 and Related Developments
7.2 Omron
7.2.1 Omron Business Overview
7.2.2 Omron Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.2.3 Omron Inhalation Therapy Nebuliser Product Introduction
7.2.4 Omron Response to COVID-19 and Related Developments
7.3 Drive DeVilbiss Healthcare
7.3.1 Drive DeVilbiss Healthcare Business Overview
7.3.2 Drive DeVilbiss Healthcare Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.3.3 Drive DeVilbiss Healthcare Inhalation Therapy Nebuliser Product Introduction
7.3.4 Drive DeVilbiss Healthcare Response to COVID-19 and Related Developments
7.4 Philips
7.4.1 Philips Business Overview
7.4.2 Philips Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.4.3 Philips Inhalation Therapy Nebuliser Product Introduction
7.4.4 Philips Response to COVID-19 and Related Developments
7.5 Yuwell
7.5.1 Yuwell Business Overview
7.5.2 Yuwell Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.5.3 Yuwell Inhalation Therapy Nebuliser Product Introduction
7.5.4 Yuwell Response to COVID-19 and Related Developments
7.6 Leyi
7.6.1 Leyi Business Overview
7.6.2 Leyi Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.6.3 Leyi Inhalation Therapy Nebuliser Product Introduction
7.6.4 Leyi Response to COVID-19 and Related Developments
7.7 Folee
7.7.1 Folee Business Overview
7.7.2 Folee Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.7.3 Folee Inhalation Therapy Nebuliser Product Introduction
7.7.4 Folee Response to COVID-19 and Related Developments
7.8 Medel S.p.A
7.8.1 Medel S.p.A Business Overview
7.8.2 Medel S.p.A Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.8.3 Medel S.p.A Inhalation Therapy Nebuliser Product Introduction
7.8.4 Medel S.p.A Response to COVID-19 and Related Developments
7.9 Briggs Healthcare
7.9.1 Briggs Healthcare Business Overview
7.9.2 Briggs Healthcare Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.9.3 Briggs Healthcare Inhalation Therapy Nebuliser Product Introduction
7.9.4 Briggs Healthcare Response to COVID-19 and Related Developments
7.10 3A Health Care
7.10.1 3A Health Care Business Overview
7.10.2 3A Health Care Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.10.3 3A Health Care Inhalation Therapy Nebuliser Product Introduction
7.10.4 3A Health Care Response to COVID-19 and Related Developments
7.11 Trudell Medical International
7.11.1 Trudell Medical International Business Overview
7.11.2 Trudell Medical International Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.11.3 Trudell Medical International Inhalation Therapy Nebuliser Product Introduction
7.11.4 Trudell Medical International Response to COVID-19 and Related Developments
7.12 GF Health Products
7.12.1 GF Health Products Business Overview
7.12.2 GF Health Products Inhalation Therapy Nebuliser Quarterly Production and Revenue, 2020
7.12.3 GF Health Products Inhalation Therapy Nebuliser Product Introduction
7.12.4 GF Health Products Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Inhalation Therapy Nebuliser Supply Chain Analysis
8.1.1 Inhalation Therapy Nebuliser Supply Chain Analysis
8.1.2 Covid-19 Impact on Inhalation Therapy Nebuliser Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Inhalation Therapy Nebuliser Distribution Channels
8.2.2 Covid-19 Impact on Inhalation Therapy Nebuliser Distribution Channels
8.2.3 Inhalation Therapy Nebuliser Distributors
8.3 Inhalation Therapy Nebuliser Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Inhalation Therapy Nebuliser Assessment
Table 9. COVID-19 Impact: Inhalation Therapy Nebuliser Market Trends
Table 10. COVID-19 Impact Global Inhalation Therapy Nebuliser Market Size
Table 11. Global Inhalation Therapy Nebuliser Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Inhalation Therapy Nebuliser Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Inhalation Therapy Nebuliser Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Inhalation Therapy Nebuliser Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Inhalation Therapy Nebuliser Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Inhalation Therapy Nebuliser Market Growth Drivers
Table 17. Global Inhalation Therapy Nebuliser Market Restraints
Table 18. Global Inhalation Therapy Nebuliser Market Opportunities
Table 19. Global Inhalation Therapy Nebuliser Market Challenges
Table 20. Key Manufacturers Inhalation Therapy Nebuliser Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Inhalation Therapy Nebuliser Market Size, 2019 (K Units) & (US$ Million)
Table 22. Inhalation Therapy Nebuliser Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Inhalation Therapy Nebuliser Manufacturing Plants
Table 24. Key Manufacturers Inhalation Therapy Nebuliser Market Served
Table 25. Date of Key Manufacturers Enter into Inhalation Therapy Nebuliser Market
Table 26. Key Manufacturers Inhalation Therapy Nebuliser Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Inhalation Therapy Nebuliser Market Size by Type, 2020, (US$ Million)
Table 29. Global Inhalation Therapy Nebuliser Market Size by Type, 2020 (K Units)
Table 30. Global Inhalation Therapy Nebuliser Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Inhalation Therapy Nebuliser Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Inhalation Therapy Nebuliser Market Size by Application, 2020-2021 (K Units)
Table 33. Global Inhalation Therapy Nebuliser Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Inhalation Therapy Nebuliser Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Inhalation Therapy Nebuliser Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Inhalation Therapy Nebuliser Market Size, 2019-2021 (K Units)
Table 38. US Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Inhalation Therapy Nebuliser Market Size, 2019-2021 (K Units)
Table 43. Germany Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Inhalation Therapy Nebuliser Market Size, 2019-2021 (K Units)
Table 50. China Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Inhalation Therapy Nebuliser Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. PARI GmbH Business Overview
Table 58. PARI GmbH Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. PARI GmbH Inhalation Therapy Nebuliser Product
Table 60. PARI GmbH Response to COVID-19 and Related Developments
Table 61. Omron Business Overview
Table 62. Omron Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Omron Inhalation Therapy Nebuliser Product
Table 64. Omron Response to COVID-19 and Related Developments
Table 65. Drive DeVilbiss Healthcare Business Overview
Table 66. Drive DeVilbiss Healthcare Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Drive DeVilbiss Healthcare Inhalation Therapy Nebuliser Product
Table 68. Drive DeVilbiss Healthcare Response to COVID-19 and Related Developments
Table 69. Philips Business Overview
Table 70. Philips Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Philips Inhalation Therapy Nebuliser Product
Table 72. Philips Response to COVID-19 and Related Developments
Table 73. Yuwell Business Overview
Table 74. Yuwell Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Yuwell Inhalation Therapy Nebuliser Product
Table 76. Yuwell Response to COVID-19 and Related Developments
Table 77. Leyi Business Overview
Table 78. Leyi Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Leyi Inhalation Therapy Nebuliser Product
Table 80. Leyi Response to COVID-19 and Related Developments
Table 81. Folee Business Overview
Table 82. Folee Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Folee Inhalation Therapy Nebuliser Product
Table 84. Folee Response to COVID-19 and Related Developments
Table 85. Medel S.p.A Business Overview
Table 86. Medel S.p.A Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Medel S.p.A Inhalation Therapy Nebuliser Product
Table 88. Medel S.p.A Response to COVID-19 and Related Developments
Table 89. Briggs Healthcare Business Overview
Table 90. Briggs Healthcare Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Briggs Healthcare Inhalation Therapy Nebuliser Product
Table 92. Briggs Healthcare Response to COVID-19 and Related Developments
Table 93. 3A Health Care Business Overview
Table 94. 3A Health Care Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. 3A Health Care Inhalation Therapy Nebuliser Product
Table 96. 3A Health Care Response to COVID-19 and Related Developments
Table 97. Trudell Medical International Business Overview
Table 98. Trudell Medical International Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Trudell Medical International Inhalation Therapy Nebuliser Product
Table 100. Trudell Medical International Response to COVID-19 and Related Developments
Table 101. GF Health Products Business Overview
Table 102. GF Health Products Inhalation Therapy Nebuliser Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. GF Health Products Inhalation Therapy Nebuliser Product
Table 104. GF Health Products Response to COVID-19 and Related Developments
Table 105. Inhalation Therapy Nebuliser Distributors List
Table 106. Inhalation Therapy Nebuliser Customers List
Table 107. Covid-19 Impact on Inhalation Therapy Nebuliser Customers
List of Figures
Figure 1. Inhalation Therapy Nebuliser Product Picture
Figure 2. Inhalation Therapy Nebuliser Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Inhalation Therapy Nebuliser Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Inhalation Therapy Nebuliser Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Inhalation Therapy Nebuliser Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Inhalation Therapy Nebuliser Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Inhalation Therapy Nebuliser Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Inhalation Therapy Nebuliser Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Inhalation Therapy Nebuliser Market Size Market Share, 2019-2021
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...